SCHEMBL17755758

SCHEMBL17755758

C[C@H](Cc1noc2c1CCCC2)C(=O)Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.47
▸ LMNA P02545 4/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ NPC1 O15118 11/20 0.46
▸ RAB9A P51151 11/20 0.46
▸ SMN1; SMN2 Q16637 8/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ RECQL P46063 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ TP53 P04637 4/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17755755 1.00 ALDH1A1 (0.47) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755720 0.77 NPC1 (0.48) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755750 0.77 MEN1 (0.48) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755744 0.77 MEN1 (0.48) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755760 0.75 ALDH1A1 (0.48) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755753 0.75 ALDH1A1 (0.48) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755774 0.71 NPC1 (0.47) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL17755754 0.69 MEN1 (0.48) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL17755756 0.69 MEN1 (0.48) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL2845806 0.69 MEN1 (0.79) ALDH1A1LMNAMAPK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2016-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137639-A1 TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF CYP3A7, CYP2C19, CYP3A5 ALDH1A1 560/4885LMNA 4195/4885MAPK1 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback